EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A comprehensive review of synthetic and semisynthetic xanthine oxidase inhibitors: identification of potential leads based on in-silico computed ADME characteristics

Rupali Rana, Anchal Sharma, Nitish Kumar, Aanchal Khanna, Jyoti, Muskan Dhir, Harmandeep Kaur Gulati, Jatinder Vir Singh, Preet Mohinder Singh Bedi

Molecular Diversity · 2025-10 · 29 (5) · 4727-4764

DOI: 10.1007/s11030-024-10962-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Diversity, online erschienen am 20.08.2024. Verfasst von Rupali Rana und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, 143005, India. rupalipharma.rsh@gndu.ac.in. Hauptthemen laut MEDLINE: Xanthine Oxidase, Enzyme Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Xanthine oxidase (XO) inhibitors, both synthetic and semisynthetic, have been developed extensively over the past few decades. The increased level of XO is not only the major cause of gout but is also responsible for various conditions associated with hyperuricemia, such as cardiovascular disorders, chronic kidney disorders, diabetes, Alzheimer's disease and chronic wounds. Marketed available XO inhibitors (allopurinol, febuxostat, and topiroxostat) are used to treat hyperuricemia but they are associated with fatal side effects, which pose serious problems for the healthcare system, rising the need for new, more potent, safer compounds. This review summarizes recent findings on XO and describes their design, synthesis, biological significance in the development of anti-hyperuricemic drugs with ADME profile, structure activity relationship (SAR) and molecular docking studies. The results might help medicinal chemists to develop more efficacious XO inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Xanthine OxidaseEnzyme InhibitorsHumansMolecular Docking SimulationStructure-Activity RelationshipHyperuricemiaComputer SimulationDrug Design

Stichwörter der Autor:innen

GoutMolecular dockingSemi-syntheticStructure activity relationshipSyntheticUric acidXanthine oxidase

Substanzen

Xanthine OxidaseEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, 143005, India. rupalipharma.rsh@gndu.ac.in.
  • Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, 143005, India. anchalsharma4619@gmail.com.
  • Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab, 143005, India.
  • Drug and Pollution Testing Laboratory, Guru Nanak Dev University, Amritsar, Punjab, 143005, India.

Zitieren

APA

Rana, R., Sharma, A., Kumar, N., Khanna, A., Jyoti, Dhir, M., Gulati, H. K., Singh, J. V., & Bedi, P. M. S. (2025). A comprehensive review of synthetic and semisynthetic xanthine oxidase inhibitors: identification of potential leads based on in-silico computed ADME characteristics. Molecular Diversity, 29(5), 4727-4764. https://doi.org/10.1007/s11030-024-10962-1

Vancouver

Rana R, Sharma A, Kumar N, Khanna A, Jyoti, Dhir M, et al. A comprehensive review of synthetic and semisynthetic xanthine oxidase inhibitors: identification of potential leads based on in-silico computed ADME characteristics. Molecular Diversity. 2025;29(5):4727-4764. doi:10.1007/s11030-024-10962-1

BibTeX
@article{Rana2025,
  author = {Rana, Rupali and Sharma, Anchal and Kumar, Nitish and Khanna, Aanchal and Jyoti and Dhir, Muskan and Gulati, Harmandeep Kaur and Singh, Jatinder Vir and Bedi, Preet Mohinder Singh},
  title = {A comprehensive review of synthetic and semisynthetic xanthine oxidase inhibitors: identification of potential leads based on in-silico computed ADME characteristics},
  journal = {Molecular Diversity},
  year = {2025},
  volume = {29},
  number = {5},
  pages = {4727--4764},
  doi = {10.1007/s11030-024-10962-1}
}
Kostenlos starten →